O
OrbiMed’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Sell |
341,900
-4,200
| -1% | -$1.37M | 2.78% | 11 |
|
|
2025
Q1 | $93.5M | Sell |
346,100
-69,500
| -17% | -$18.8M | 2.23% | 14 |
|
|
2024
Q4 | $97.8M | Buy |
415,600
+165,300
| +66% | +$38.9M | 2.01% | 14 |
|
|
2024
Q3 | $68.8M | Hold |
250,300
| – | – | 1.25% | 25 |
|
|
2024
Q2 | $60.8M | Buy |
+250,300
| New | +$60.8M | 1.2% | 24 |
|
|
2024
Q1 | – | Sell |
-79,400
| Closed | -$15.2M | – | 114 |
|
|
2023
Q4 | $15.2M | Buy |
+79,400
| New | +$15.2M | 0.3% | 69 |
|
|
2022
Q4 | – | Sell |
-250,500
| Closed | -$50.1K | – | 116 |
|
|
2022
Q3 | $50.1K | Buy |
+250,500
| New | +$50.1K | 0.93% | 39 |
|
|
2018
Q3 | – | Sell |
-1,265,966
| Closed | -$125M | – | 148 |
|
|
2018
Q2 | $125M | Hold |
1,265,966
| – | – | 1.49% | 20 |
|
|
2018
Q1 | $151M | Buy |
1,265,966
+324,366
| +34% | +$38.6M | 1.87% | 15 |
|
|
2017
Q4 | $120M | Sell |
941,600
-143,200
| -13% | -$18.2M | 1.51% | 21 |
|
|
2017
Q3 | $127M | Buy |
1,084,800
+445,600
| +70% | +$52.4M | 1.22% | 27 |
|
|
2017
Q2 | $51M | Buy |
639,200
+557,000
| +678% | +$44.4M | 0.53% | 56 |
|
|
2017
Q1 | $4.21M | Buy |
+82,200
| New | +$4.21M | 0.05% | 116 |
|